WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Sushil Kumar
PeerJ Reviewer
415 Points

Contributions by role

Reviewer 15
Editor 400

Contributions by subject area

Gastroenterology and Hepatology
Pediatrics
Biochemistry
Cell Biology
Genetics
Molecular Biology
Oncology
Histology
Immunology

Sushil Kumar

PeerJ Reviewer

Summary

Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.

Biochemistry Biotechnology Cell Biology Immunology Metabolic Sciences Molecular Biology Oncology Translational Medicine Virology

Past or current institution affiliations

Oregon Health Sciences University

Work details

Research Assistant Professor

Oregon Health Sciences University
June 2012
Cell Development and Cancer Biology

PeerJ Contributions

  • Edited 3

Academic Editor on

April 19, 2023
Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway
Zhuo Zhang, Duoli Zhang, Fang Wang, Jiao Liu, Yuhong Sun, Songyot Anuchapreeda, Singkome Tima, Zhangang Xiao, Suwit Duangmano
https://doi.org/10.7717/peerj.15172 PubMed 37096066
March 17, 2023
Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization
Chenghao Yi, Shilong Wu, Qianyu Duan, Lei Liu, Li Li, Yonghui Luo, Anan Wang
https://doi.org/10.7717/peerj.15060 PubMed 36949762
May 29, 2018
Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
Xiao-Yong Zhan, Yaqiong Zhang, Ertao Zhai, Qing-Yi Zhu, Yulong He
https://doi.org/10.7717/peerj.4829 PubMed 29868263